Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Thorax

• Publication date

  2009-01-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.2008.105312PMID 19131448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Markers of treatment failure in hospitalised community acquired pneumonia

  2009cited by this paper
• Markers of treatment failure in hospitalised community acquired pneumonia

  2008cited by this paper
• Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes

  2008cited by this paper
• C-reactive protein is an independent predictor of severity in community-acquired pneumonia.

  2008cited by this paper
• Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators

  2007cited by this paper
• Recent Advances in Community-Acquired Pneumonia

  2007cited by this paper
• Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.

  2007cited by this paper
• Validation of a predictive rule for the management of community-acquired pneumonia

  2006cited by this paper
• Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]

  2006cited by this paper
• The systemic response to lung infection.

  2005cited by this paper
• Applied Logistic Regression: Hosmer/Applied Logistic Regression

  2005cited by this paper
• Causes and predictors of nonresponse to treatment of intensive care unit–acquired pneumonia*

  2004cited by this paper
• Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

  2003cited by this paper
• Molecular Inflammatory Responses Measured in Blood of Patients with Severe Community-Acquired Pneumonia

  2003cited by this paper
• Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism.

  2003cited by this paper
• Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study.

  2002cited by this paper
• Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States.

  2002influential reference
• Novel nonantibiotic therapies for pneumonia: cytokines and host defense.

  2001cited by this paper
• Anti-inflammatory treatment of acute and chronic pneumonia.

  2001cited by this paper
• Severity prediction rules in community acquired pneumonia: a validation study

  2000cited by this paper
• Epidemiology of community-acquired pneumonia in adults: a population-based study.

  2000cited by this paper
• Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population.

  1999cited by this paper
• Trends in infectious disease mortality in the United States during the 20th century.

  1999cited by this paper
• Cytokine expression in severe pneumonia: a bronchoalveolar lavage study.

  1999cited by this paper
• A prediction rule to identify low-risk patients with community-acquired pneumonia.

  1997cited by this paper
• A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

  1983cited by this paper

• Biomarker-guided use of corticosteroids in pneumonia

  2026cites this paper
• Treatment outcomes and predictors of clinical response in patients with community-acquired pneumonia at Hai Phong International Hospital: A retrospective cohort study

  2026cites this paper
• Proadrenomedullin for prediction of early and mid-term mortality in patients hospitalized for community-acquired pneumonia

  2025cites this paper
• Derivation and validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) score: A prospective cohort study.

  2025cites this paper
• Effectiveness of Corticosteroid Strategy in Three Community‐Acquired Pneumonia Clinical Phenotypes: A Multicenter Retrospective Cohort Study

  2025cites this paper
• Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines

  2025cites this paper
• Metabolic Disturbances Associated with In-Hospital Complication and Mortality in Different Types of Pneumonia

  2024cites this paper
• Evaluation of the Relationship Between Biomarkers and Disease Severity in Patients with Community-Acquired Pneumonia

  2024cites this paper
• Improving prognostication of pneumonia among elderly patients: usefulness of suPAR

  2024cites this paper
• The Role of Biomarkers in Influenza and COVID-19 Community-Acquired Pneumonia in Adults

  2023cites this paper
• Diagnostic and Prognostic Roles of Procalcitonin and Other Tools in Community-Acquired Pneumonia: A Narrative Review

  2023cites this paper
• Validation of risk prediction for outcomes of severe community-acquired pneumonia among under-five children in Amhara region, Northwest Ethiopia

  2023cites this paper
• The Value of Biological Markers in Assessing the Severity of Community-Acquired Pneumonia

  2023cites this paper
• Prevalence and impact of malnutrition on outcomes and mortality of under-five years children with pneumonia: a study from Upper Egypt

  2023cites this paper
• Federal guidelines on diagnosis and treatment of community-acquired pneumonia

  2022cites this paper
• Can neutrophil-to-lymphocyte ratio and proatherogenic risk factors improve the accuracy of pneumonia severity index in the prediction of community acquired pneumonia outcome in healthy individuals?

  2022cites this paper
• Diagnostic and Prognostic Value of Deregulated Circulating Long Non-coding RNA TUG1 in Elderly Patients with Severe Pneumonia

  2022cites this paper
• A retrospective observational study of biomarker levels and severity assessment in pediatric community-acquired pneumonia

  2022cites this paper
• N-myc and STAT interactor is a novel biomarker of severity in community-acquired pneumonia: a prospective study

  2022cites this paper
• Novel Immunomodulatory Therapies for Respiratory Pathologies

  2022cites this paper
• Additive effectiveness of acrylonitrile‐co‐methallyl sulfonate surface‐treated membranes in the treatment of pneumonia: A propensity score‐matched retrospective cohort study

  2022cites this paper
• Mid-regional pro-adrenomedullin as a predictor of in-hospital mortality in adult patients with COVID-19: a single-centre prospective study

  2022cites this paper
• A new predictive tool consolidating CURB-65 with procalcitonin and albumin to assess short-term mortality in hospitalized elderly patients with infectious disease: A retrospective study of a patient cohort

  2022cites this paper
• Severe community-acquired pneumonia in adults. Clinical recommendations from Russian Federation of Anaesthesiologists and Reanimatologists

  2022cites this paper
• The ARREST Pneumonia (Arrest Respiratory Failure due to Pneumonia) Trial: Rationale and Design.

  2021cites this paper
• The ARREST Pneumonia Clinical Trial

  2021cites this paper
• A literature review of severity scores for adults with influenza or community-acquired pneumonia – implications for influenza vaccines and therapeutics

  2021cites this paper
• Early and Significant Reduction in C-Reactive Protein Levels After Corticosteroid Therapy Is Associated With Reduced Mortality in Patients With COVID-19.

  2021cites this paper
• Comparison of the efficacy of PSI, CURB-65, CALL and BCRSS in predicting prognosis and mortality in COVID-19 patients

  2021cites this paper
• Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital

  2020cites this paper
• Biomarker-Concordant Steroid Use in Critically Ill Patients with Pneumonia

  2020cites this paper
• Biomarkers in Community-Acquired Pneumonia (Cardiac and Non-Cardiac)

  2020cites this paper
• Association of acute phase reactants with prognostic scores in community acquired pneumonia.

  2020cites this paper
• C-reactive protein for simple prediction of mortality in patients with acute non-variceal upper gastrointestinal bleeding

  2020cites this paper
• In-Hospital Mortality After Blood Purification With and Without Acrylonitrile-Co-Methallyl Sulfonate Surface-Treated Membrane for Pneumonia-Associated Sepsis: A Retrospective Cohort Study

  2020cites this paper
• Development and Internal Validation of a Prediction Model to Risk Stratify Children with Suspected Community-Acquired Pneumonia.

  2020cites this paper
• Impact of chronic obstructive pulmonary disease on mortality in community acquired pneumonia: a meta-analysis.

  2020cites this paper
• Ischemic Necrosis of Lower Extremity in COVID-19: A Case Report

  2020cites this paper
• Admission IL-32 Concentration Predicts Severity and Mortality of Severe Community-Acquired Pneumonia Independently of Etiology.

  2020cites this paper
• Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Mean platelet volume change (∆MPV) and red blood cell distribution width (RDW) as promising markers of community-acquired pneumonia (CAP) outcome

  2020cites this paper
• Usefulness of mean platelet volume to platelet count ratio for predicting the risk of mortality in community-acquired pneumonia

  2020cites this paper
• Predictive value of proadrenomedullin in patients with COVID-19

  2020cites this paper
• How biomarkers can improve pneumonia diagnosis and prognosis: procalcitonin and mid-regional-pro-adrenomedullin.

  2020cites this paper
• Clinical and laboratory predictors of 30‐day mortality in severe acute malnourished children with severe pneumonia

  2020cites this paper
• Usefulness of Early C-Reactive Protein Kinetics in Response and Prognostic Assessment in Infected Critically Ill Patients: An Observational Retrospective Study.

  2019cites this paper
• Molecular Diagnostics in Pulmonary Infections

  2019cites this paper
• Adjunct corticosteroid treatment in patients with pneumonia: A precision medicine approach.

  2019cites this paper
• The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.

  2019cites this paper
• Prognostic Value of Procalcitonin in Pneumonia among Patients Admitted to Intensive Care Unit.

  2019cites this paper
• Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia

  2019cites this paper
• Hot topics and current controversies in community-acquired pneumonia

  2019cites this paper
• Outpatient management of community-acquired pneumonia

  2019cites this paper
• Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital

  2019cites this paper
• CURB 65 score as a predictor of early mortality in hospital-acquired pneumonia

  2019cites this paper
• Meta-analysis of Calibration, Discrimination, and Stratum-Specific Likelihood Ratios for the CRB-65 Score

  2019cites this paper
• Relationship Between the Serum Level of C-Reactive Protein and Severity and Outcomes of Community-acquired Pneumonia

  2019cites this paper
• Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review

  2019cites this paper
• Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit: Propensity score‐based analysis of a before‐after cohort study

  2018cites this paper
• Biomarkers improves prognostic and mortality prediction in pneumonia

  2018cites this paper
• Sepsis and community-acquired pneumonia

  2018cites this paper
• Prognostic factors for mortality due to pneumonia among adults from different age groups in Singapore and mortality predictions based on PSI and CURB-65.

  2018cites this paper
• Severity scoring systems for pneumonia: current understanding and next steps

  2018cites this paper
• Development of array systems for molecular diagnostic assays

  2018cites this paper
• Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017

  2018cites this paper
• Initial Inflammatory Profile in Community‐acquired Pneumonia Depends on Time since Onset of Symptoms

  2018cites this paper
• Personalizing the Management of Pneumonia.

  2018cites this paper
• Integrated traditional Chinese and conventional medicine in treatment of severe community-acquired pneumonia: study protocol for a randomized placebo-controlled trial

  2018cites this paper
• Diagnostic and predictive values of procalcitonin in bloodstream infections for nosocomial pneumonia

  2018cites this paper
• A small pericardial effusion is a marker of complicated hospitalization in patients with community‐acquired pneumonia☆

  2018cites this paper
• Adjunct Corticosteroid Therapy for Patients with Community Acquired Pneumonia

  2018cites this paper
• Adjuvant therapies in critical care: steroids in community-acquired pneumonia

  2017cites this paper
• Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia

  2017cites this paper
• Lymphopenic community acquired pneumonia, an unnoticed phenotype associated to mortality in non immuno-suppressed patients: a retrospective cohort study

  2017cites this paper
• Predicting 30-day mortality in hospitalized patients with community-acquired pneumonia using statistical and machine learning approaches.

  2017cites this paper
• Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.

  2017cites this paper
• Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial

  2017cites this paper
• Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality

  2017cites this paper
• Cytokine responses, microbial aetiology and short‐term outcome in community‐acquired pneumonia

  2017cites this paper
• Usefulness and prognostic value of biomarkers in patients with community-acquired pneumonia in the emergency department.

  2017cites this paper
• Tools for outcome prediction in patients with community acquired pneumonia

  2017cites this paper
• Utilidad y valor pronóstico de los biomarcadores en los pacientes con neumonía adquirida en la comunidad en los servicios de urgencias

  2017cites this paper
• Failure of CRP decline within three days of hospitalization is associated with poor prognosis of Community-acquired Pneumonia

  2017cites this paper
• University of Louisville Journal of Respiratory Infections Using Steroids in Patients with Community-Acquired Pneumonia at the University of Louisville Hospital : Who , What , and When

  2017cites this paper
• PROGNOSTIC VALUE OF PRO-ADRENOMEDULLIN, PROCALCITONIN AND C-REACTIVE PROTEIN IN COMMUNITY ACQUIRED PNEUMONIA

  2017cites this paper
• mproved Management of Community-Acquired Pneumonia in the mergency Department

  2017cites this paper
• Community-Acquired Pneumonia 2000-2015: What is New?

  2016cites this paper
• Serial procalcitonin levels for predicting prognosis in community‐acquired pneumonia

  2016cites this paper
• Multimarker Prognostication for Hospitalized Patients with Community-acquired Pneumonia.

  2016cites this paper
• Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis

  2016cites this paper
• Serum procalcitonin and C-reactive protein kinetics as indicators of treatmentoutcome in hospitalized patients with community-acquired pneumonia.

  2016cites this paper
• A New Prognosis Score to Predict Mortality After Acute Pneumonia in Very Elderly Patients.

  2016cites this paper
• Arguments in Favor of Corticosteroids in Pneumonia Corticoides en la neumonía: argumentos a favor

  2016cites this paper
• Can N-terminal pro B-type natriuretic peptide, neutrophil-to-lymphocyte ratio, C-reactive protein help to predict short and long term mortality?

  2016cites this paper
• A novel method for rapid detection of Streptococcus pneumoniae antigens in blood.

  2016cites this paper
• Actualización en el tratamiento de las neumonías

  2016cites this paper
• Evaluación y predicción del riesgo de mala evolución de la neumonía adquirida en la comunidad

  2016cites this paper
• Precision medicine for the treatment of severe pneumonia in intensive care

  2016cites this paper
• CRP/IL-6/IL-10 Single-Nucleotide Polymorphisms Correlate with the Susceptibility and Severity of Community-Acquired Pneumonia

  2016cites this paper
• Nonantibiotic Adjunctive Therapies for Community-Acquired Pneumonia (Corticosteroids and Beyond): Where Are We with Them?

  2016cites this paper